Close

Analyst Ratings for Ultragenyx Pharma (RARE)

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $89.60 (+108.5%) * Over Last 12-Mos
Rating Score: 7.3 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/18/2023 Canaccord Genuity Whitney Ijem New Coverage Buy
(N/A)
N/A
(N/A)
42.50
(42.98)
1.13% Details
12/30/2022 H.C. Wainwright Ed Arce New Coverage Buy
(N/A)
82.00
(N/A)
45.17
(42.98)
-4.85% Details
Like RARE Ratings? Also take a look at MREO, ABEO, JAZZ, PCOR

RARE Ratings News